JC

James Campbell

Prescient Therapeutics Limited | Non-Executive Director, Non-Executive Chairman
Dr Campbell has more than 25 years of international biotechnology research, management and leadership experience and has been involved in the creation and/or transformation of multiple Australian and international biotechnology companies. He was foundation executive of Evolve Biosystems, and has assisted private biotechnology companies in Australia, New Zealand and the USA with successful capital raising and partnering negotiations. He is a member of Risk and Governance Committee.

Company and Roles

Company
Title
Tenure
Since
PTX
PTX
Prescient Therapeutics Limited
  • Non-Executive Director
  • Non-Executive Chairman
11yrs, 10mthNov 2014

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PTX
PTX
Prescient Therapeutics Limited
30/09/26550,211972,0005,257,573N/A
PAB
PAB
22/10/2512,947,115194,0080N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PTX
PTX
Prescient Therapeutics Limited
30/09/26
Buy
153,846$0.065$9,999Participation in share purchase plan
PTX
PTX
Prescient Therapeutics Limited
18/11/25
Issued
5,257,573$0.048$252,363Issue of options
PAB
PAB
22/10/25
Issued
10,701,795$0.015$160,526Issue of securities
PAB
PAB
30/09/25
Expiry
23,389,950$0.002$46,779Options expired
PAB
PAB
28/08/25
Issued
16,296,678$0.002$32,593Rights issue